Vymada | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

35 results for “Vymada”

Trials

Active, not recruiting

Investigating the Effectiveness of Vimida

160 participants · First posted Feb 9, 2024

Phase II/III Study of an Alpha-1 Proteinase Inhibitor (Kamada-API) in Individuals With Alpha-1 Antitrypsin Deficiency

50 participants · First posted Apr 13, 2007

Not yet recruiting

Vimala Massage Infantile Colic, Sleep and Development Levels

72 participants · First posted May 29, 2025

Drugs

Cholesterol Lowering Program(Nyrada)

Rho (D) immunoglobulin (Kamada)

Brain Injury Program(Nyrada)

Organizations

Kamada

Israel

YAMADA MINORU

Japan

Kamada Ltd.

Israel

News

View all 11 →

Indian Patent Office Revokes Novartis' Vymada Patent, Opening Door for Generic Competition

Nyrada's NYR-BI03 Advances to Phase I Trials After Promising Preclinical Safety Results

Kamada Announces Reduced Sample Size for Inhaled AAT Phase 3 Trial Following FDA Feedback

Page 1 of 4